| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |